A Shostak
Overview
Explore the profile of A Shostak including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
42
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dai C, Brissova M, Hang Y, Thompson C, Poffenberger G, Shostak A, et al.
Diabetologia
. 2011 Dec;
55(3):707-18.
PMID: 22167125
Aims/hypothesis: Our understanding of the transcription factors that control the development and function of rodent islet beta cells is advancing rapidly, yet less is known of the role they play...
2.
Gotloib L, Wajsbrot V, Shostak A
Int J Artif Organs
. 2005 Mar;
28(2):97-104.
PMID: 15770597
Peritoneal sclerosis has been induced in rodents in vivo by exposing the membrane to a variety of experimental interventions: asbestos, 0.1% chlorexidine, iron dextran, glucose degradation products, AGE deposits derived...
3.
Topczewska J, Topczewski J, Shostak A, Kume T, Hogan B
Genes Dev
. 2001 Sep;
15(18):2483-93.
PMID: 11562356
Previous studies identified zebrafish foxc1a and foxc1b as homologs of the mouse forkhead gene, Foxc1. Both genes are transcribed in the unsegmented presomitic mesoderm (PSM), newly formed somites, adaxial cells,...
4.
Shostak A, Wajsbrot V, Gotloib L
Microvasc Res
. 2001 Mar;
61(2):166-78.
PMID: 11254396
This study evaluates albuminuria and peritoneal permeability to albumin in control and diabetic rats, as well as in diabetic animals treated with subcutaneously injected aminoguanidine hydrochloride (Ag) (5 mg/100 g/day),...
5.
Shostak A, Wajsbrot V, Gotloib L
Kidney Int
. 2000 Oct;
58(5):2044-52.
PMID: 11044224
Background: Mouse mesothelium exposed in vivo for 30 days to high glucose solutions develop morphological changes that characterize a population of cells near the end of their life span. Methods:...
6.
Gotloib L, Shostak A, Wajsbrot V
Perit Dial Int
. 2000 Jul;
20 Suppl 2:S11-4.
PMID: 10911636
No abstract available.
7.
Shostak A, Gotloib L, Kushnier R, Wajsbrot V
Nephron
. 2000 Apr;
84(4):362-6.
PMID: 10754414
Rat peritoneal mesothelial cells in culture have the capability of generating hydrogen peroxide. Exposure of these cells to glucose-enriched, lactated-buffered fluids for peritoneal dialysis significantly increases the production of H(2)O(2)....
8.
Gotloib L, Shostak A, Wajsbrot V, Kushnier R
Nephron
. 1999 Jun;
82(2):164-73.
PMID: 10364709
Previous studies, done using our mouse model for population analysis of the mesothelium, showed evidence indicating that in vivo, long-term exposure (up to 30 days) of the peritoneum to high-glucose...
9.
Gotloib L, Wajsbrot V, Shostak A, Kushnier R
Nephron
. 1999 Mar;
81(3):301-9.
PMID: 10050085
Studies done using the in vivo mouse model of population analysis of mesothelium showed that dialysis solutions containing high concentrations of glucose induced the development of a hypertrophic phenotype. Since...
10.
Jaichenko J, Fudin R, Shostak A, Gotloib L
Nephron
. 1998 Nov;
80(3):367-8.
PMID: 9807055
No abstract available.